Tech Company Financing Transactions

ai3Bio Funding Round

UPMC Enterprises, Ziff Capital Partners and Cockrell Interests participated in a $48 million Series A capital raise for ai3Bio. The financing round was announced on 9/29/2026.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

99 Coolidge Ave 201
Watertown, MA 02472
USA

Phone

Undisclosed

Website

www.ai3.bio

Email Address

[email protected]

Overview

Our Vision: By resetting the immune system at its root, ai3Bio aims to move autoimmune care from a lifetime of management toward lasting remission for millions of patients. Our Mission: The immune system is meant to protect the body, but for more than 15 million Americans, it turns against them instead.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Steven Altschuler

        

Chief Financial Officer

Nick Seaver

        

Chief Technical Officer

Michael Lyman

        

Browse more venture capital transactions:

Prev: 9/29/2026: RemoteThreat venture capital transaction
Next: 9/29/2026: Breye Therapeutics venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary